Faeth Therapeutics, Inc.
FTH
$32.34
$3.7913.28%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.21M | 19.71M | 2.79M | 2.32M | 2.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.39M | 170.63M | 4.96M | 4.85M | 5.21M |
| Operating Income | -18.39M | -170.63M | -4.96M | -4.85M | -5.21M |
| Income Before Tax | -16.01M | -170.24M | -4.72M | -4.57M | -4.94M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.01M | -170.24M | -4.72M | -4.57M | -4.94M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.01M | -170.24M | -4.72M | -4.57M | -4.94M |
| EBIT | -18.39M | -170.63M | -4.96M | -4.85M | -5.21M |
| EBITDA | -18.36M | -170.60M | -4.92M | -4.82M | -5.17M |
| EPS Basic | -2.84 | -131.45 | -3.74 | -3.62 | -3.91 |
| Normalized Basic EPS | -1.77 | -82.21 | -2.40 | -2.26 | -2.45 |
| EPS Diluted | -2.84 | -131.45 | -3.74 | -3.62 | -3.91 |
| Normalized Diluted EPS | -1.77 | -82.21 | -2.40 | -2.26 | -2.45 |
| Average Basic Shares Outstanding | 5.64M | 1.30M | 1.26M | 1.26M | 1.26M |
| Average Diluted Shares Outstanding | 5.64M | 1.30M | 1.26M | 1.26M | 1.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |